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The tuberculin skin test (TST) is a model of integrated innate and adaptive human immune
responses to Mycobacterium tuberculosis, but the component processes that are involved in
this model have not previously been defined in vivo. We used transcriptional profiling to
study these responses within the TSTat molecular and system levels. Skin biopsies from TST
injection sites were examined in subjects classified as TST1 or TST by clinical and histo-
logical criteria. Genome-wide expression arrays showed evolution of immune responses
reflecting T-cell activation and recruitment with uniquely Th1-polarized responses and
cytotoxic T cells (CTLs). In addition, distinct innate immune and IFN-c-stimulated gene
expression signatures were identified, under the regulation of NF-jB and STAT1 transcrip-
tional control. These were highly enriched for chemokines and MHC class II molecules
providing a potential mechanism for paracrine amplification of inflammatory responses in
the TST, by supporting cellular recruitment and enhancing antigen presentation. The same
repertoire of innate and adaptive immune responses was evident in TST1 and TST subjects
alike, clinically positive TSTs being distinguished only by quantitatively greater differences.
These data provide new insights into complex multifaceted responses within the TST, with
much greater sensitivity than previous clinical or histological assessments.
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Introduction
The current understanding of host defense against mycobacteria
and the immunopathogenesis of tuberculosis (TB) is modelled on
delayed-type hypersensitivity (DTH). This is a paradigm of
complex immune responses at the interface of innate and
adaptive immunity. In this model, innate immune cellular
activation of mononuclear phagocytic cells leads to recruitment
of circulating immune cells and activation of T cells bearing
cognate T-cell receptors. In the presence of appropriate co-
stimulatory signals, Th1 type responses associated with produc-
tion of IFN-g and consequently IFN-g-stimulated processes follow.
This component is an important factor in local paracrine
amplification of the inflammatory response and activation of
cell-mediated antimicrobial killing.
However, our understanding of the interface between innate
and adaptive human immune responses relies heavily on in vitro or
ex vivo models. In vivo studies of the molecular components of
complex immunological processes within the tissue micro-
environment are needed to test these models in man. A classic
paradigm of DTH, which might be amenable to such an approach,
is represented by the tuberculin skin test (TST). The TST is
regarded as an index of the presence of T-cell memory for myco-
bacterial antigens in the clinical assessment of TB. However,
considerable discordance between TSTs and quantitation of anti-
mycobacterial T-cell memory in peripheral blood is recognized [1].
For example, deficient DTH responses are seen in the skin of
elderly subjects or amongst HIV co-infected patients, despite
preserved peripheral blood T-cell responses [2–4]. Although the
TST has been assessed by histology and immunostaining
previously [2, 5, 6], many questions remain unresolved. In parti-
cular, little is known about the innate immune and IFN-g-stimu-
lated responses in the TST. Similarly, our understanding of the
mechanisms that underlie TST anergy, which is known to arise in
elderly patients with TB, patients with miliary TB or with TB/HIV
co-infection, and in patients with sarcoidosis, is incomplete. To
obtain new insights into the immunological features of the TST at
a molecular level, we performed transcriptional profiling of skin
biopsy samples from subjects categorized as TST1 and TST by
conventional clinical and histological criteria. We focussed on gene
expression signatures for innate immune responses, differential
T-cell responses, and responses stimulated by IFN-g.
Our hypothesis was that early innate immune gene expression
would be independent of T-cell memory for mycobacterial anti-
gens, and would be augmented only in the presence of Th1
responses accompanied by molecular evidence for IFN-g-stimu-
lated gene expression. Here, we present findings that identify
innate and IFN-g-stimulated gene expression signatures in
samples from TST1 subjects, and show evidence for T-cell acti-
vation, Th1-polarized responses and CTLs, but not for cell
proliferation, implying that immune responses were predomi-
nantly due to cell recruitment. Unexpectedly, however, identical
gene expression patterns were observed in subjects judged to be
TST on conventional criteria, and samples from TST1 subjects
were distinguished only by quantitative differences.
Results
Microarray gene expression profiles in early and late
TST biopsies
Healthy HIV-1 volunteers from the UK and South Africa (SA),
representing an ethnically diverse study sample with mixed
exposure history to mycobacteria and BCG vaccination, were
subjected to concurrent TSTs in each arm and skin biopsies for
histology and transcriptional profiling at 6 and 48h. Clinical and
histological classification of 48-h TST skin biopsy samples
(Fig. 1A) was concordant in every instance apart from one SA
subject who was clinically negative, but had histological inflam-
mation, and was therefore included in the TST1 group for
subsequent analysis. Demographic data, clinical measurements of
the TST response and results of peripheral blood IFN-g release
assays (IGRA) are summarized in Supporting Information Table 1.
Genome-wide transcriptional profiles of 6 and 48-h samples
from four TST1 subjects and four TST subjects, with the best
RNA quality and equal representation from UK and SA groups
(indicated in Supporting Information Table 1), were compared
by principle component analysis (PCA). In this approach to
represent multidimensional gene expression data, principle
component (PC) scores reflect the magnitude of differences and
each component reflects different dimensions of the gene
expression data. The component of the data responsible for the
greatest variance, denoted principle component (PC)1, clearly
showed differential clustering of gene expression profiles of 48-h
biopsies from TST1 and TST subjects, and from all 6-h biopsies,
which clustered together (Fig. 1B). Functional annotation clus-
tering analysis of the gene list that generated the top 10% of the
total variance, identified from the PCA (factor) loadings in PC1,
showed highly significant enrichment for gene ontology clusters
involving immune responses (Fig. 1C). These data confirm that
gene expression profiling may be used to assess evolution of
complex immune responses in vivo within the TST. Evolution of
immunological responses in 48-h samples from TST subjects
was also evident, suggesting that gene expression profiling
provides more sensitive assessment of the TST than previous
clinical or histological studies. The finding that these gene
expression changes occur in the same PC as those of 48-h samples
from TST1 subjects suggests that immune responses in TST
subjects are qualitatively similar, but quantitatively less than
those of TST1 subjects.
T-cell gene expression profiles in TSTs
Th1 responses are thought to be important determinants of DTH
and immune responses to Mycobacterium tuberculosis (Mtb), but
the roles of alternatively polarized Th subsets, T regulatory
(Treg) cells and CTLs (CD81ve) have not been established in vivo.
Therefore, we used selected gene expression profiles reflecting
T-cell subsets [7, 8] together with a panel of T-cell activation and
proliferation markers, to probe transcriptional profiles in TST
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samples (Fig. 2). Expression of genes associated with T-cell
activation, Th1 responses and CTLs was higher (4two-fold) in
48-h biopsies compared to 6-h biopsies and in 48-h samples from
TST1 compared to TST subjects. In contrast, there was no
consistent difference in expression of genes associated with T-cell
proliferation, Th2 or Th17-polarized responses or Treg cells.
Thus, the 48-h TST is associated with uniquely Th1-polarized
responses and CTL gene expression profiles that were evident in
samples from both TST and TST1 subjects, albeit with lower
gene expression levels in TST subjects. Of note, our data showed
no detectable increase in expression of natural killer cell markers,
such as CD56, CD57 or killer cell immunoglobulin-like receptors,
that may also generate IFN-g responses (not shown), supporting
the conclusion that increased IFN-g gene expression reflected Th1
activity.
Innate immune and IFN-c-stimulated gene expression
signatures in the TST
Although simple observational studies suggest that the TST
response involves interactions between mononuclear phagocytes
and T cells, the TST has been interpreted almost exclusively as a
reflection of anti-mycobacterial T-cell memory. Thus, very little is
known about the innate immune and IFN-g-stimulated responses.
To explore this, we generated a specific transcriptional signature
of the response of human macrophages stimulated in vitro with
Figure 1. Transcriptional profiling of the TST. TST site skin biopsies
from all 20 participants (40 biopsies) were stained with haematoxylin
and eosin for histological analysis. (A) Representative histology from
6- and 48-h TST samples is shown. Arrows indicate areas of prominent
intradermal inflammatory infiltrate in a localized perivascular distri-
bution. No inflammatory infiltrate was seen in 6-h biopsy samples or in
the 48-h samples from TST subjects (scale bar5 400 mM). (B) Principle
component analysis (PCA) of microarray data from TST1 and TST
individuals (data points represent mean7SEM of PC scores from four
separate subjects in each group). (C) Functional annotation clustering
of the 250 genes which displayed the largest expression changes
within PC1 was performed to show significantly enriched gene
ontology groups (Modified Fisher’s Exact Test).
Figure 2. T-cell gene expression signatures in the TST. Transcriptional
responses of gene sets representative of T helper and cytotoxic T-cell
subsets as well as T-cell activation and proliferation markers are
summarized by alignment with expression matrices showing either
relative expression or mean fold differences in 6-h compared with 48-h
biopsies from TST1 and TST subjects. Data represent mean gene
expression values of four samples in each group.
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either Mtb or IFN-g. These two signatures showed little overlap
(Fig. 3 and Supporting Information Fig. 1). Alignment of all
significant gene expression differences induced by either stimulus
shows that IFN-g and Mtb induce distinct transcriptional
responses, albeit with modest overlap after 24-h Mtb stimulation.
The same finding is reflected in the PCA, which shows that
changes to transcriptional profiles following innate immune
responses to Mtb or stimulation with IFN-g are evident in
different components. Therefore, we used these distinct gene lists
to probe the gene expression data from skin samples for innate
and IFN-g-stimulated responses. TST data were subjected to PCA
and quantitative differences in each gene signature were
represented by the PC1 scores, which reflect the greatest gene
expression differences between samples. In this analysis, each set
of genes, showed comparable gene expression profiles at 6-h. All
48-h samples clustered separately from 6-h samples, and 48-h
samples from TST1 subjects showed greater differences than
those from TST subjects (Fig. 4A).
Immune response amplification in the TST
The innate and IFN-g-stimulated gene expression signatures
associated with development of the TST were analysed further by
assessment of gene ontology associations of the genes within
each signature, in which expression levels increased (4two-fold)
in 48-h samples compared to 6-h samples. Functional annotation
clustering analysis revealed that the top three enriched
clusters included defense response genes in both data sets,
cytokines and chemokines or genes associated with regulation of
apoptosis in innate immune signatures (Fig. 4B), and genes
associated with antigen presentation or lymphocyte activation in
IFN-g-stimulated signatures (Fig. 4C). Specific analysis of
enrichment for gene ontology by molecular function terms of
the combined innate and IFN-g-stimulated genes that were
increased within 48-h TST samples, showed striking enrichment
for cytokines, and a wide repertoire of chemokines and MHC
class II pathway components (Fig. 5). This analysis provides a
putative molecular mechanism for robust paracrine amplification
of the inflammatory response, mediated by chemokine and
Figure 3. Discrimination of innate immune and IFN-g-stimulated gene
expression signatures in monocyte-derived macrophages. (A) Upregu-
lation of gene expression in monocyte-derived macrophages (MDMs)
stimulated for 4–24 h with Mtb (as an innate immune stimulus) or with
10 ng/mL IFN-g. Three separate experiments from different donors for
each stimulation group were compared with eight separate experi-
ments from different donors for unstimulated MDMs. (B) All significant
gene expression differences were aligned in an expression matrix
representing mean fold change compared with unstimulated MDMs.
(C) The differences in transcriptional profiles from unstimulated MDMs
and Mtb or IFN-g-stimulated MDMs were also assessed by PCA (data
points represent mean7SEM of PC scores).
Figure 4. Innate immune and IFN-g-stimulated gene expression
signatures in the TST. (A) The major differences identified by PCA
and represented by the PC1 score in transcriptional profiles from TST
arrays in TST1 and TST subjects were compared for Mtb or IFN-g-
stimulated gene lists (data points represent mean7SEM of PC scores
from four separate subjects in each group). Among genes that showed
increased expression in 48-h TST samples (4two-fold over 6-h
samples), the top three significantly enriched gene ontology associa-
tions are shown, in either (B) innate immune or (C) IFN-g-stimulated
gene expression signatures (Modified Fisher’s Exact Test). (D) These in
vivo signatures were subjected to transcription factor binding site
enrichment analysis to determine the putative transcriptional regula-
tors of each response. In this analysis, z-scores of 410 are considered
to indicate highly significant over-representation of transcription
factor binding sites within the analysed gene list.
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cytokine-induced recruitment and activation of lymphocytes,
associated with increased MHC class II expression which
enhances capacity for antigen presentation. Here again, qualita-
tively similar but quantitatively smaller changes were evident in
TST subjects.
Transcriptional regulation of immune responses in the
TST
The transcriptional regulation underlying these gene expression
changes was investigated by in silico analysis of transcription
factor binding motifs in the promoter regions of the genes from
innate or IFN-g signatures that showed increased expression in
48-h TST samples (Fig. 4D). Binding sites for the NF-kB family
were the most highly enriched within the innate immune gene
signature, whereas binding sites for STAT1 were most highly
enriched among the IFN-g-stimulated genes. These data provide
in vivo confirmation of the central roles of NF-kB and STAT1 in
transcriptional regulation of innate immune and IFN-g-stimu-
lated responses respectively.
Validation of microarray data by qPCR
Gene expression patterns identified by microarray analysis in the
sample of the study group were validated in all 20 participants
(40 samples) by qPCR of selected genes representative of each
component of the TST response (Fig. 6). In comparison to gene
expression levels in 6-h TST samples, significantly higher levels of
innate immune response genes (TNF-a and IL12B), Th1 associated
response genes (IFN-g and Tbet (T-box transcription factor
TBX21)) and IFN-g-inducible genes (IFIT2 (IFN-induced protein
with tetratricopeptide repeats 2)) were all evident in all 48-h
samples. In each case, gene expression was greater in 48-h
samples from TST1 subjects compared to TST subjects, although
this did not reach statistical significance for IL12B. In contrast,
expression of the transcriptional regulator of Th2 responses did
not increase between 6- and 48-h samples and was not
significantly different between TST1 and TST subjects, thereby
Figure 5. Enriched molecular function gene ontology terms in
innate and IFN-g-stimulated genes within the TST. Mean (relative)
expression levels within the TST samples (N5 4 in each group)
are presented for innate immune and IFN-g-stimulated genes,
which showed upregulated expression in 48-h TST and were associated
with the top three enriched molecular function gene ontology
terms shown.
Figure 6. Validation of microarray data by qPCR. Quantitative PCR of
selected genes representative of innate immune responses (TNF-a and
IL12B), Th1 responses (IFN-g and Tbet), Th2 responses (GATA3) and
IFN-g-stimulated responses (IFIT2) are shown. Relative gene expression
levels are represented in comparison to GAPDH within each sample.
Box and whisker plots represent median values, interquartile ranges
and 90th percentiles for TST subjects (N5 9) and TST1 subjects
(N5 11) at each time point. po0.05, Mann–Whitney U test.
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mirroring the microarray data that also showed no evidence for a
Th2 component within the TST. The variance in these gene
expression data is clearly evident. We found no systematic
differences between the UK and SA subjects. In addition, we
found no consistent correlation with the magnitude of TST
responses clinically, or with IGRA results and no correlation with
BCG status. However, the sample size may be insufficient to make
firm conclusions and we are extending these studies to explore
these correlations further.
Discussion
The TST has been the cornerstone for in vivo assessments of
immune responses to Mtb and is the prototypic example of DTH.
In clinical practice, it has been interpreted almost exclusively as a
reflection of anti-mycobacterial T-cell memory, although the
response is thought to involve interactions between mononuclear
phagocytes and T cells. Thus, there has been almost no regard for
the role of innate immune and IFN-g-stimulated responses, and
there has also been no qualitative assessment of T-cell responses
within tissue microenvironments in humans. There is increasing
awareness, however, that such studies are important. In the
present study, the application of genome-wide transcriptional
profiling of TSTs not only supports many aspects of the existing
model of DTH but also provides new insights. It illustrates the
potential to probe complex immune responses in vivo at a
molecular level and thus achieve better understanding of
immunopathogenesis that may inform development of new
diagnostic or therapeutic strategies.
Our data are in keeping with the existing model of immunity
to mycobacteria, emphasizing the role of Th1 responses, invol-
vement of effector CTLs, and confirming for the first time in
human in vivo studies that a Th1 response is associated with
increased expression of Tbet, the master Th1 transcriptional
regulator [8]. In contrast, gene expression signatures for alter-
natively polarized or Treg cells are absent. However, Th17
responses in vitro develop over 5–10 days [9], and thus the
possible emergence of additional T-cell responses at later time
point merits further investigation. The lack of transcriptional
evidence for cellular proliferation suggests that these responses
are due to T-cell recruitment. Local expansion of antigen-specific
cells is not a component of the evolving immune response over
this time scale. The proportion of the T-cell response, which is
antigen-specific, was not assessed directly in this study, but our
findings are consistent with data from skin blister models used to
study DTH responses to tuberculin, showing little T-cell prolif-
eration or antigen-specific responses at 48–72h [10].
We show for the first time that the TST harbours specific gene
expression signatures for in vivo innate immune responses,
invoked by stimulation of macrophages with live Mtb, and IFN-g-
stimulated responses. Equivalent expression of innate immune
signatures in TST1 and TST subjects at 6 h suggested that innate
immunity was not the critical determinant of the divergence of
immune responses at 48 h. Importantly, innate immune respon-
ses incorporate multiple homeostatic mechanisms that are
involved in the resolution of inflammation [11]. Nonetheless, the
48-h time course assessed here showed increased innate immune
inflammatory responses in all subjects. In view of the concomi-
tant functionally significant Th1 response, demonstrated by
expression of IFN-g-stimulated gene signatures, and the estab-
lished role of IFN-g to support paracrine innate immune ampli-
fication [12], the increase in innate immune responses over time
is likely to have been driven by the Th1 response.
In this respect, ontological analysis of the innate and
IFN-g-regulated genes within the TST samples showed clear
evidence of the two major amplification loops that are pivotal to
DTH responses. First, there was significant enrichment of chemo-
kines and cytokines associated with regulating migration of
leukocytes into inflamed tissues, the processes which are presumed
to drive the formation of the inflammatory infiltrate that is the
hallmark of the TST response. Second, there was significant
enrichment for genes coding for components of the class II antigen
processing and presentation pathway. Lymphocyte recruitment
and activation, which then enhances the activity of APCs, can
thereby generate robust paracrine amplification of the inflamma-
tory response. Bioinformatic analysis of transcriptional control of
the genes involved in these processes provided novel in vivo
confirmation of the canonical roles for NF-kB and STAT1 in human
innate immune and IFN-g-stimulated signaling pathways respec-
tively. Further analysis and validation of individual genes within
these distinct components of the TST provides an unprecedented
opportunity to investigate the molecular details of human anti-
mycobacterial immune responses specifically and DTH responses
more generally, as they actually occur in vivo.
Transcriptional profiling has provided new qualitative and
quantitative measurements of the TST. We have shown that the
TST is a multifaceted immune response involving Th1-polarized
cells, CTLs, and both innate immune and IFN-g-stimulated
responses, which can be evaluated reproducibly at a molecular
level in the human tissue microenvironment. Conventional
evaluation of the TST has not provided a consistent measure of
susceptibility to TB, and the data presented here do not address
this directly, but we were particularly interested to see clear
evidence for immunological responses in 48-h samples from TST
subjects. This finding implies that gene expression profiling
provides significantly more sensitive assessment of the TST than
previous clinical or histological studies. Our results show the
potential to use gene expression profiling to obtain valuable
immunological data from subjects who have clinically negative
TSTs, and hence extend the research applications of this test. In
the present study, there were only quantitative differences in
otherwise similar immune responses between TST1 and TST
subjects. Although some subjects may be exhibiting a primary
immune response, the evolution of the response was qualitatively
similar in all subjects. Whether TST skin test anergy and discor-
dance between peripheral blood and skin tests might be due to
quantitative or qualitative differences in immune responses is of
particular interest. Therefore, we propose that transcriptional
profiling of TSTs can be applied to broaden our understanding of
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changes in human immunity to mycobacteria associated with
diverse causes, including malnutrition or ageing, immunosup-
pressive therapies, co-infection with HIV or helminths and in
sarcoidosis, in order to obtain new insights in the immunological
correlates of protection and pathogenicity in TB.
Materials and methods
TSTs
HIV seronegative healthy volunteers were recruited from
University College London (UK) and the University of Cape
Town (SA). The study was approved by research ethics
committees of both institutions and written informed consent
was obtained from all participants. TSTs were performed by
intradermal injection of 2U Tuberculin (Serum Statens Institute)
into each forearm. Two 3-mm punch skin biopsies were taken at
one site after 6 h, and two further biopsies taken after clinical
assessment at the contralateral site at 48 h. Biopsies were
collected into RNAlater (Qiagen) for RNA extraction, or snap
frozen for histological analysis. A positive TST was defined
clinically as induration 410mm in diameter at 48 h. TST1
patients were evaluated according to local clinical practices in
participating UK and SA centres to ensure that they did not have
active tuberculosis.
Mtb-specific IFN-c release assays
Peripheral blood samples were obtained for QuantiFERON-TB
Gold (Cellestis) in UK samples and T-Spot.TB (Oxford Immunotec)
tests in SA samples, according to manufacturers’ instructions. In
samples with adequate numbers of peripheral blood mononuclear
cells, responses to 10 mg/mL Mtb purified protein derivative
stimulation were also assessed in the ELISpot assays.
Histological assessment
Ten-micrometer frozen sections were stained with haemotoxylin
and eosin and viewed with a Zeiss Axioplan 2 microscope. Digital
images were acquired with Axiophot software (version 1.2) and
are presented without any subsequent processing. The presence
or absence of an inflammatory infiltrate was recorded blind.
Monocyte-derived macrophage (MDMs) in vitro stimu-
lation experiments
MDM differentiated with macrophage–colony stimulating factor
were generated as described previously [13] and stimulated for
4–24 h, with Mtb (H37Rv) at a multiplicity of infection of one, or
with 10 ng/mL IFN-g (Peprotech).
Transcriptional profiling by cDNA microarray
Total RNA from skin biopsies was obtained with the Lipid Tissue
RNEasy kit (Qiagen), and from MDM lysates collected in TRIzol
(Invitrogen), with the PureLink RNA kit (Invitrogen). Samples
were processed for Agilent microarrays and data were normal-
ized as previously described [14, 15]. PCA was used to compare
global gene expression profiles and t tests were used to identify
significant gene expression differences between samples. DAVID
functional annotation clustering (http://david.abcc.ncifcrf.gov)
was used to annotate gene lists of interest by gene ontology
associations. Transcriptional regulation of specific gene signa-
tures was assessed by analysis of single transcription factor
binding site enrichment analysis (http://www.cisreg.ca/cgi-bin/
oPOSSUM/opossum). Microarray data are available in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress) under
accession number (E-TABM-1157).
Quantitative PCR detection of gene transcription
First strand cDNA was synthesized using the qScript cDNASuper-
mix kit (Quanta BioSciences) and quantitative (q)PCR of selected
genes was performed as previously described [15] using the
following TaqMan inventoried assays: TNFa (Hs00174128_m1),
IFN-g (Hs00174143_m1), Tbet (Hs00894392_m1), IL12B
(Hs99999037_m1), GATA3 (GATA binding protein 3)
(Hs00231122_m1) and IFIT2 (Interferon-induced protein with
tetratricopeptide repeats 2) (Hs00533665_m1).
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